- 24.03.2011, 12:38:46
- /
- OTE0009
EANS-Voting Rights: Sartorius AG / Correction of a release according to article 26, section 1 WpHG (Securities Trading Act) with the aim of Europe-wide distribution from Mrz 23, 2011 at 10:34
--------------------------------------------------------------------------------
Notification of voting rights transmitted by euro adhoc. The issuer is
responsible for the content of this announcement.
--------------------------------------------------------------------------------
Announcement according to Article 21, Section 1 of the WpHG (share)
Correction of voting rights notification as of 23 March 2011
according to sec. 26 subsection 1 German Securities Trading Act (WpHG)
Pursuant to sec. 21 subsection 1 WpHG Biorad Laboratories, Inc., Hercules,
California, USA, has informed us on March 18, 2011 of the following:
1. Pursuant to sec. 21 subsection 1 WpHG Biorad Laboratories, Inc., has informed
us in the name and on behalf of its subsidiary Bio-Rad Holding LLC, Hercules,
California, USA, that the share of voting rights of its subsidiary on October 3,
2003 has exceeded the thresholds of 5% and 10% and on that day totaled 13.38% of
the voting rights (1,252,647 voting rights) in Sartorius AG.
Of these voting rights 13.38% (1,252,647 voting rights) are to be attributed
pursuant to sec. 22 subsection 1 sentence 1 no. 1 WpHG.
Voting rights that are to be attributed are held via the following companies
which are controlled by Bio-Rad Holding LLC and whose holdings of voting rights
amount to 3% each or more in Sartorius AG:
- Bio-Rad Laboratories GmbH
2. Pursuant to sec. 21 subsection 1 WpHG Biorad Laboratories, Inc., has informed
us in the name and on behalf of its subsidiary Bio-Rad Holding LLC that the
share of voting rights of its subsidiary on November 24, 2003 has fallen below
the thresholds of 10% and 5% and on that day totaled 0% (0 voting rights) of the
voting rights in Sartorius AG.
Pursuant to sec. 21 subsection 1 WpHG Biorad Laboratories, Inc., has informed us
in the name and on behalf of its subsidiary Bio-Rad Laboratories ApS, Kobenhavn,
Denmark, that the share of voting rights of its subsidiary on November 24, 2003
has exceeded the thresholds of 5% and 10% and on that day totaled 14.10%
(1,320,137 voting rights) of the voting rights in Sartorius AG.
Of these voting rights 14.10% (1,320,137 voting rights) are to be attributed
pursuant to sec. 22 subsection 1 sentence 1 no. 1 WpHG.
Voting rights that are to be attributed are held via the following companies
which are controlled by Bio-Rad Laboratories ApS and whose holdings of voting
rights amount to 3% each or more in Sartorius AG:
- Bio-Rad France Holding SAS
- Bio-Rad Laboratories GmbH
Pursuant to sec. 21 subsection 1 WpHG Biorad Laboratories, Inc., has informed us
in the name and on behalf of its subsidiary Bio-Rad France Holding SAS,
Marnes-la-Coquet, France, that the share of voting rights of its subsidiary on
November 24, 2003 has exceeded the thresholds of 5% and 10% and on that day
totaled 14.10% (1,320,137) of the voting rights in Sartorius AG.
Of these voting rights 14.10% (1,320,137 voting rights) are to be attributed
pursuant to sec. 22 subsection 1 sentence 1 no. 1 WpHG.
Voting rights that are to be attributed are held via the following companies
which are controlled by Bio-Rad France Holding SAS and whose holdings of voting
rights amount to 3% each or more in Sartorius AG:
- Bio-Rad Laboratories GmbH
3. Pursuant to sec. 21 subsection 1 WpHG Biorad Laboratories, Inc., has informed
us in the name and on behalf of its subsidiary Bio-Rad Laboratories ApS that the
share of voting rights of its subsidiary on September 13, 2006 has exceeded the
threshold of 25% and on that day totaled 25.02% (2,341,479 voting rights) of the
voting rights in Sartorius AG.
Of these voting rights 25.02% (2,341,479 voting rights) are to be attributed
pursuant to sec. 22 subsection 1 sentence 1 no. 1 WpHG.
Voting rights that are to be attributed are held via the following companies
which are controlled by Bio-Rad Laboratories ApS and whose holdings of voting
rights amount to 3% each or more in Sartorius AG:
- Bio-Rad France Holding SAS
- Bio-Rad Laboratories GmbH
Pursuant to sec. 21 subsection 1 WpHG Biorad Laboratories, Inc., has informed us
in the name and on behalf of its subsidiary Bio-Rad France Holding SAS that the
share of voting rights of its subsidiary on September 13, 2006 has exceeded the
threshold of 25% and on that day totaled 25.02% (2,341,479 voting rights) of the
voting rights in Sartorius AG.
Of these voting rights 25.02% (2,341,479 voting rights) are to be attributed
pursuant to sec. 22 subsection 1 sentence 1 no. 1 WpHG.
Voting rights that are to be attributed are held via the following companies
which are controlled by Bio-Rad France Holding SAS and whose holdings of voting
rights amount to 3% each or more in Sartorius AG:
- Bio-Rad Laboratories GmbH
4. Pursuant to sec. 21 subsection 1 WpHG Biorad Laboratories, Inc., has informed
us in the name and on behalf of its subsidiary Bio-Rad Luxembourg S.à.r.l.,
Luxembourg, Luxembourg, that the share of voting rights of its subsidiary on
December 19, 2007 has exceeded the thresholds of 3%, 5%, 10%, 15%, 20% and 25%
and on that day totaled 25.19% (2,357,480 voting rights) of the voting rights in
Sartorius AG.
Of these voting rights 25.19% (2,357,480 voting rights) are to be attributed
pursuant to sec. 22 subsection 1 sentence 1 no. 1 WpHG.
Voting rights that are to be attributed are held via the following companies
which are controlled by Bio-Rad Luxembourg S.à.r.l. and whose holdings of voting
rights amount to 3% each or more in Sartorius AG:
- Bio-Rad Laboratories ApS
- Bio-Rad France Holding SAS
- Bio-Rad Laboratories GmbH
5. Pursuant to sec. 21 subsection 1 WpHG Biorad Laboratories, Inc., inform us in
the name and on behalf of its subsidiary Bio-Rad Laboratories ApS that the share
of voting rights of its subsidiary on March 17, 2008 has fallen below the
thresholds of 25%, 20%, 15%, 10%, 5% und 3% and on that day totaled 0% (0 voting
rights) of the voting rights in Sartorius AG.
Further inquiry note:
Katrin Sebastian
Stellvertret. Leiterin Konzernrechtsabteilung
Tel.: 0049 (0) 551 308 3849
E-Mail: [email protected]
end of announcement euro adhoc
--------------------------------------------------------------------------------
issuer: Sartorius AG
Weender Landstr. 94-108
D-37075 Göttingen
phone: +49 (0)551 308-0
FAX: +49 (0)551 308-3289
mail: [email protected]
WWW: http://www.sartorius.com
sector: Biotechnology
ISIN: DE0007165607, DE0007165631
indexes: CDAX, Prime All Share, Technology All Share
stockmarkets: regulated dealing/prime standard: Frankfurt, free trade: Berlin,
Hamburg, Stuttgart, Düsseldorf, Hannover, München
language: English
OTS-ORIGINALTEXT PRESSEAUSSENDUNG UNTER AUSSCHLIESSLICHER INHALTLICHER VERANTWORTUNG DES AUSSENDERS - WWW.OTS.AT | OTB
